-
Targeted sequencing of paired tumour/blood of 34 T1 stage bladder cancer patients
Study
EGAS00001005767
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005230
-
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Study
EGAS00001005769
-
Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing
Study
EGAS00001004289
-
MethCORR: DNA Methylation-based Characterization, Classification and Prognostication of Colorectal Cancer using Archival Formalin-fixed, Paraffin-embedded Tissue
Study
EGAS00001004293
-
The Landscape of Genetic Alterations in Hepatocellular Carcinoma, 88 matched HCC tumour/normal pairs WGS belongs to ICGC LICA-CN project
Study
EGAS00001002218
-
Rare occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Study
EGAS00001005909
-
Hereditary Cancer Diagnostics with I2HCP gene panel
Study
EGAS00001004316
-
WGS_of_AML_during_PARPi_therapy
Study
EGAS00001002274
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Nanopore_and_Illumina_sequencing_of_human_glioblastomas
Study
EGAS00001005812
-
Oesophageal_Adenocarcinoma_Organoid_10x
Study
EGAS00001003191
-
Comprehensive molecular characterization of brainstem glioma
Study
EGAS00001004341
-
DNA sequencing for human normal endometrial glands
Study
EGAS00001005822
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
Target gene sequencing for human normal endometrial glands
Study
EGAS00001005914
-
Genomic determination for Homologous Recombination Deficiency (HRD) by shallow Whole Genome Sequencing (sWGS)
Study
EGAS00001005926
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Study
EGAS00001002699
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Study
EGAS00001005963
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)
Study
EGAS00001004370
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Temporal stability of circulating microRNAs in human serum
Study
EGAS00001003221
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016
-
Personalised Mapping of Tumour Development in Synchronous Colorectal Cancer Patients
Study
EGAS00001004413
-
Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Study
EGAS00001004431
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Patient-derived organoids as a novel tool to study cervical cancer
Study
EGAS00001004439
-
Methylome sequencing of cell-free DNA and RRBS of solid tissue
Study
EGAS00001006020
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445